Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin to Reduce AF Burden Post-Ablation (DAPA-AF)
NCT04792190Phase 4Completed
- Sponsor
- University of Rochester
- Start
- Jul 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in Atrial fibrillation (AFib), sponsored by University of Rochester. Started Jul 2021; status: completed.
02
Drugs
dapagliflozin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04792190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04792190.